Advertisement
Screener

TG THERAPEUTICS, INC. (TGTX) Auditor

TG THERAPEUTICS, INC. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-02-27: Fiscal year end 2025-12-31; Auditor KPMG LLP; PCAOB firm ID 185; Location New York, NY.
  • 2025-03-03: Fiscal year end 2024-12-31; Auditor KPMG LLP; PCAOB firm ID 185; Location New York, NY.
  • 2024-08-09: Fiscal year end 2023-12-31; Auditor KPMG LLP; PCAOB firm ID 185; Location New York, NY.
  • 2024-02-29: Fiscal year end 2023-12-31; Auditor KPMG LLP; PCAOB firm ID 185; Location New York, NY.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-02-272025-12-31KPMG LLP185New York, NYYes
2025-03-032024-12-31KPMG LLP185New York, NYYes
2024-08-092023-12-31KPMG LLP185New York, NYYes
2024-02-292023-12-31KPMG LLP185New York, NYYes
2023-03-012022-12-31KPMG LLP185New York, NYYes
2022-03-012021-12-31KPMG LLP185New York, NYYes
2021-03-012020-12-31CohnReznick LLPNew York, New York
2020-03-022019-12-31CohnReznick LLPNew York, New York
2019-03-012018-12-31CohnReznick LLPYork, New York
2018-03-152017-12-31CohnReznick LLPYork, New York
2017-03-162016-12-31CohnReznick LLPYork, New York
2016-03-152015-12-31CohnReznick LLPRoseland, New Jersey
2015-03-162014-12-31CohnReznick LLPRoseland, New Jersey
2014-03-072013-12-31CohnReznick LLPRoseland, New Jersey
2013-03-212012-12-31CohnReznick LLPRoseland, New Jersey
2012-03-142011-12-31J.H. Cohn LLPRoseland, New Jersey
2011-03-312010-12-31J.H. Cohn LLPRoseland, New Jersey

Similar stocks

Stock NameCountryMarket CapPE Ratio
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52
CYTOKINETICS INC (CYTK)United States$9.130B-11.86
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28
Praxis Precision Medicines, Inc. (PRAX)United States$7.884B-27.60
Structure Therapeutics Inc. (GPCR)United States$7.710B-53.41
Spyre Therapeutics, Inc. (SYRE)United States$7.685B-43.69
Axsome Therapeutics, Inc. (AXSM)United States$10.274B-66.82
IONIS PHARMACEUTICALS INC (IONS)United States$7.277B-23.25
Alkermes plc. (ALKS)$6.844B132.74
RHYTHM PHARMACEUTICALS, INC. (RYTM)United States$6.771B-37.20